fbpx

People with tuberous sclerosis complex (TSC) face many medical issues as they age, including new-onset seizures or ongoing epilepsy. Studies indicate more than 80% of individuals with TSC will develop epilepsy at some point in their life. 

Many individuals will face the onset of seizures before the age of 3. There is always a risk of infantile spasms in individuals from birth to the age of 2. It is not uncommon for individuals to develop new seizures or to experience a return of seizures after being well controlled for long periods of time.

Some individuals with TSC, who did not have seizures as a child, could begin having seizures as adults. Generally, the seizure type(s) experienced by adults with TSC will be more easily treated with anti-seizure medications than childhood-onset seizures.

Occasionally, the onset of seizures will result from a buildup of pressure in the brain due to the presence of a subependymal giant cell astrocytoma (SEGA), a non-cancerous tumor that occurs in about 15% of individuals with TSC. Individuals with TSC often undergo magnetic resonance imaging (MRI) of the brain throughout adolescence and early adulthood (at least until the age of 21 years) to monitor for the presence and growth of a SEGA.

In adults with TSC who have been previously undiagnosed, the first sign of the tumor may be blurring of vision and/or the onset of seizures, but the symptoms may be more subtle. A brain MRI can reveal whether a SEGA may be blocking the flow of cerebrospinal fluid around the brain, causing increased pressure on the brain. In many individuals, the SEGA can be removed by surgery. Everolimus was approved by the Food and Drug Administration (FDA) in October 2010 for treatment of TSC-associated SEGAs that are not candidates for curative surgery.

Evaluation of new-onset seizures in adults 

Issues for women with TSC

Issues for men with TSC

Reviewed by Ashley Pounders, MSN, FNP-C, November 2023.

Thank you to our TSC Navigator supporters:

Northstar Sponsors

  • Jazz Pharmaceuticals 
  • UCB, Inspired by patients. Driven by science.

Cardinal Sponsors

  • Neurelis
  • Nobel Pharma

Directional Sponsor

  • Noema